<SEC-DOCUMENT>0001193125-26-299290.txt : 20260709
<SEC-HEADER>0001193125-26-299290.hdr.sgml : 20260709
<ACCEPTANCE-DATETIME>20260709093132
ACCESSION NUMBER:		0001193125-26-299290
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		11
CONFORMED PERIOD OF REPORT:	20260702
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20260709
DATE AS OF CHANGE:		20260709

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			FibroBiologics, Inc.
		CENTRAL INDEX KEY:			0001958777
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				863329066
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-41934
		FILM NUMBER:		261164259

	BUSINESS ADDRESS:	
		STREET 1:		9350 KIRBY DRIVE
		STREET 2:		SUITE 300
		CITY:			HOUSTON
		STATE:			TX
		ZIP:			77054
		BUSINESS PHONE:		281-671-5150

	MAIL ADDRESS:	
		STREET 1:		9350 KIRBY DRIVE
		STREET 2:		SUITE 300
		CITY:			HOUSTON
		STATE:			TX
		ZIP:			77054

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	FibroBiologics Inc.
		DATE OF NAME CHANGE:	20221216
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>fblg-20260702.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<!-- DFIN New ActiveDisclosure (SM) Inline XBRL Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date :2026-07-08T20:31:06.7389+00:00 -->
<!-- Copyright (c) 2026 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:nonNumeric="http://www.xbrl.org/dtr/type/non-numeric" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:dei="http://xbrl.sec.gov/dei/2026" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2022-02-16" xmlns:fblg="http://fibrobiologics.com/20260702">
 <head>
  <title>8-K</title>
  <meta http-equiv="Content-Type" content="text/html"/>
 </head>
 <body style="padding:8px;margin:auto!important;z-index:0;-webkit-text-size-adjust:100%;position:relative;">
  <div style="display:none;"><ix:header><ix:hidden><ix:nonNumeric id="F_7abf7119-9615-4c0b-9929-e4861497e7c5" name="dei:AmendmentFlag" contextRef="C_a9b4a05e-f434-40f1-aa9d-e49c11ce14e9">false</ix:nonNumeric><ix:nonNumeric id="F_5f429da3-957d-431f-b4d8-55a3194a5b34" name="dei:EntityCentralIndexKey" contextRef="C_a9b4a05e-f434-40f1-aa9d-e49c11ce14e9">0001958777</ix:nonNumeric></ix:hidden><ix:references><link:schemaRef xlink:type="simple" xlink:href="fblg-20260702.xsd"/></ix:references><ix:resources><xbrli:context id="C_a9b4a05e-f434-40f1-aa9d-e49c11ce14e9"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001958777</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2026-07-02</xbrli:startDate><xbrli:endDate>2026-07-02</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div>
  <div style="z-index:2;min-height:0.5in;position:relative;"></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="border-top:2.25pt double #000000;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:5.75pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:18pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">UNITED STATES<br/>SECURITIES AND EXCHANGE COMMISSION<br/></span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">WASHINGTON, D.C. 20549</span></p><p style="margin-left:40%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:0.75pt solid #000000;margin-right:40%;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><h2 style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:18pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">FORM </span><span style="font-size:18pt;font-family:Times New Roman;"><ix:nonNumeric id="F_c65c1e5e-9d1d-4fe9-b037-49d8c7959417" contextRef="C_a9b4a05e-f434-40f1-aa9d-e49c11ce14e9" name="dei:DocumentType"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:18pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">8-K</span></ix:nonNumeric></span></h2><p style="margin-left:40%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:0.75pt solid #000000;margin-right:40%;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">CURRENT REPORT</span></p><p style="font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:6pt;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934</span></p>
   <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
    <tr style="visibility:collapse;">
     <td style="width:100%;box-sizing:content-box;"/>
    </tr>
    <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;text-align:left;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.398%;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Date of Report (Date of earliest event reported): </span><span><ix:nonNumeric id="F_5d78c504-1783-46ca-89a6-4da7c37c9dfe" contextRef="C_a9b4a05e-f434-40f1-aa9d-e49c11ce14e9" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">July 02, 2026</span></ix:nonNumeric></span></p></td>
    </tr>
   </table><p style="margin-left:40%;font-size:10pt;margin-top:5pt;font-family:Times New Roman;margin-bottom:0;border-bottom:0.75pt solid #000000;margin-right:40%;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:5pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="font-size:24pt;font-family:Times New Roman;"><ix:nonNumeric id="F_185f6a94-5aeb-4fba-889b-76001835fbc3" contextRef="C_a9b4a05e-f434-40f1-aa9d-e49c11ce14e9" name="dei:EntityRegistrantName"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:24pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">FibroBiologics, Inc.</span></ix:nonNumeric></span></p><p style="font-size:10pt;margin-top:3pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:7.5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(Exact name of Registrant as Specified in Its Charter)</span></p><p style="margin-left:40%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;border-bottom:0.75pt solid #000000;margin-right:40%;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
   <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
    <tr style="visibility:collapse;">
     <td style="width:20%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:20%;box-sizing:content-box;"/>
     <td style="width:18%;box-sizing:content-box;"/>
     <td style="width:41%;box-sizing:content-box;"/>
    </tr>
    <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;text-align:left;">
     <td colspan="3" style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_9e2bb745-f78b-4a43-b9ca-26ecd776de39" contextRef="C_a9b4a05e-f434-40f1-aa9d-e49c11ce14e9" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Delaware</span></ix:nonNumeric></span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_84d9b4d1-b642-432b-a00d-ba02d0837c64" contextRef="C_a9b4a05e-f434-40f1-aa9d-e49c11ce14e9" name="dei:EntityFileNumber"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">001-41934</span></ix:nonNumeric></span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_1dda705e-abc3-4599-a399-1b3a7e4e9d4e" contextRef="C_a9b4a05e-f434-40f1-aa9d-e49c11ce14e9" name="dei:EntityTaxIdentificationNumber"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">86-3329066</span></ix:nonNumeric></span></p></td>
    </tr>
    <tr style="height:7pt;word-break:break-word;white-space:pre-wrap;text-align:left;">
     <td colspan="3" style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(State or Other Jurisdiction<br/>of Incorporation)</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(Commission File Number)</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(IRS Employer<br/>Identification No.)</span></p></td>
    </tr>
    <tr style="word-break:break-word;white-space:pre-wrap;text-align:left;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;text-align:left;">
     <td colspan="3" style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_03cbc71a-bf2e-468f-b123-343146e2938c" contextRef="C_a9b4a05e-f434-40f1-aa9d-e49c11ce14e9" name="dei:EntityAddressAddressLine1"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">9350 Kirby Drive, Suite 300</span></ix:nonNumeric></span></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;text-align:left;">
     <td colspan="3" style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_123de368-df3f-46e6-abe9-952a9d8fb44d" contextRef="C_a9b4a05e-f434-40f1-aa9d-e49c11ce14e9" name="dei:EntityAddressCityOrTown"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Houston</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">, </span><span><ix:nonNumeric id="F_b23f5531-23e3-42b9-bf84-d51793e66859" contextRef="C_a9b4a05e-f434-40f1-aa9d-e49c11ce14e9" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Texas</span></ix:nonNumeric></span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_271038da-9c13-403c-84b4-c477ff0f2c90" contextRef="C_a9b4a05e-f434-40f1-aa9d-e49c11ce14e9" name="dei:EntityAddressPostalZipCode"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">77054</span></ix:nonNumeric></span></p></td>
    </tr>
    <tr style="height:7pt;word-break:break-word;white-space:pre-wrap;text-align:left;">
     <td colspan="3" style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(Address of Principal Executive Offices)</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(Zip Code)</span></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
   <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
    <tr style="visibility:collapse;">
     <td style="width:100%;box-sizing:content-box;"/>
    </tr>
    <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;text-align:left;">
     <td style="padding-top:0.125in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.398%;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Registrant&#8217;s Telephone Number, Including Area Code:</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span><span><ix:nonNumeric id="F_6541e654-62ca-4d92-8fc1-91db1429686b" contextRef="C_a9b4a05e-f434-40f1-aa9d-e49c11ce14e9" name="dei:CityAreaCode"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">281</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span><span><ix:nonNumeric id="F_e1a21691-39b7-432e-b261-07f6d1c17512" contextRef="C_a9b4a05e-f434-40f1-aa9d-e49c11ce14e9" name="dei:LocalPhoneNumber"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">671-5150</span></ix:nonNumeric></span></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
   <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
    <tr style="visibility:collapse;">
     <td style="width:100%;box-sizing:content-box;"/>
    </tr>
    <tr style="word-break:break-word;white-space:pre-wrap;text-align:left;">
     <td style="padding-top:0.125in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:7.5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(Former Name or Former Address, if Changed Since Last Report)</span></p><p style="margin-left:40%;font-size:10pt;margin-top:9.35pt;font-family:Times New Roman;margin-bottom:0;border-bottom:0.75pt solid #000000;margin-right:40%;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:9.35pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><div style="text-indent:-24.5pt;padding-left:24.5pt;margin-top:3pt;margin-bottom:0;text-align:left;"><span style="margin-right:1em;margin-right:1em;"><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_608abc22-51ab-4512-a24d-f7b1727be683" contextRef="C_a9b4a05e-f434-40f1-aa9d-e49c11ce14e9" name="dei:WrittenCommunications" format="ixt-sec:boolballotbox"><span style="font-size:10pt;font-family:Times New Roman;">&#9744;</span></ix:nonNumeric></span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></div><div style="text-indent:-24.5pt;padding-left:24.5pt;margin-top:6pt;margin-bottom:0;text-align:left;"><span style="margin-right:1em;margin-right:1em;"><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_ad1599e1-cf04-4048-a91c-53ebe494e4d2" contextRef="C_a9b4a05e-f434-40f1-aa9d-e49c11ce14e9" name="dei:SolicitingMaterial" format="ixt-sec:boolballotbox"><span style="font-size:10pt;font-family:Times New Roman;">&#9744;</span></ix:nonNumeric></span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></div><div style="text-indent:-24.5pt;padding-left:24.5pt;margin-top:6pt;margin-bottom:0;text-align:left;"><span style="margin-right:1em;margin-right:1em;"><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_af21b2f4-ed42-44bb-b480-7d73e494e444" contextRef="C_a9b4a05e-f434-40f1-aa9d-e49c11ce14e9" name="dei:PreCommencementTenderOffer" format="ixt-sec:boolballotbox"><span style="font-size:10pt;font-family:Times New Roman;">&#9744;</span></ix:nonNumeric></span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></div><div style="text-indent:-24.5pt;padding-left:24.5pt;margin-top:6pt;margin-bottom:0;text-align:left;"><span style="margin-right:1em;margin-right:1em;"><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_2485b67b-8475-45a4-a3f2-bbbd34beecb2" contextRef="C_a9b4a05e-f434-40f1-aa9d-e49c11ce14e9" name="dei:PreCommencementIssuerTenderOffer" format="ixt-sec:boolballotbox"><span style="font-size:10pt;font-family:Times New Roman;">&#9744;</span></ix:nonNumeric></span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></div><p style="font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:9pt;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Securities registered pursuant to Section 12(b) of the Act:</span></p>
   <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
    <tr style="visibility:collapse;">
     <td style="width:38%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:15%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:45%;box-sizing:content-box;"/>
    </tr>
    <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;text-align:left;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.25pt solid;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"><br/>Title of each class</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.25pt solid #ffffff03;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.25pt solid;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Trading<br/>Symbol(s)</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.25pt solid #ffffff03;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.25pt solid;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"><br/>Name of each exchange on which registered</span></p></td>
    </tr>
    <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;text-align:left;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_d3096739-13e3-45a9-8357-816a4747eeca" contextRef="C_a9b4a05e-f434-40f1-aa9d-e49c11ce14e9" name="dei:Security12bTitle"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Common Stock, $0.00001 par value</span></ix:nonNumeric></span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_c220cb3e-8a66-4b30-964d-dd03a2d6e887" contextRef="C_a9b4a05e-f434-40f1-aa9d-e49c11ce14e9" name="dei:TradingSymbol"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">FBLG</span></ix:nonNumeric></span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_bb38d109-68c9-4007-a622-b0ee88f1f50d" contextRef="C_a9b4a05e-f434-40f1-aa9d-e49c11ce14e9" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">The Nasdaq Stock Market LLC</span></ix:nonNumeric></span></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;&#8239;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;&#8239;240.12b-2 of this chapter).</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Emerging growth company </span><span style="font-size:10pt;"><ix:nonNumeric id="F_be48f5ba-e685-4fad-be5c-3d5728dcc293" contextRef="C_a9b4a05e-f434-40f1-aa9d-e49c11ce14e9" name="dei:EntityEmergingGrowthCompany" format="ixt-sec:boolballotbox"><span style="font-size:10pt;font-family:Times New Roman;">&#9746;</span></ix:nonNumeric></span></p><p style="font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. </span><span style="font-size:10pt;"><ix:nonNumeric id="F_0ba7bac9-0e5a-4bee-a045-dd58db5ea521" contextRef="C_a9b4a05e-f434-40f1-aa9d-e49c11ce14e9" name="dei:EntityExTransitionPeriod" format="ixt-sec:boolballotbox"><span style="font-size:10pt;font-family:Times New Roman;">&#9744;</span></ix:nonNumeric></span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:2.25pt double #000000;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;min-height:0.5in;justify-content:flex-end;position:relative;"></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="z-index:2;min-height:0.5in;position:relative;"></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><h2 style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.</span></h2><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On July 2, 2026, Matt Link notified FibroBiologics, Inc. (the &#8220;Company&#8221;) that he was resigning from the Board of Directors (the &#8220;Board&#8221;), effective as of July 2, 2026.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On July 8, 2026, the Board appointed Kathleen Rubins, Ph.D. as a Class III director of the Board, effective July 8, 2026, to serve until the expiration of her term at the 2029 annual meeting of stockholders. Dr. Rubins was also appointed to serve on the Board&#8217;s Audit Committee, Compensation Committee and Governance and Nominating Committee.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Dr. Rubins is the Founding Director, Trivedi Institute for Space and Global Biomedicine, and a Professor of Computational and Systems Biology at the University of Pittsburgh School of Medicine. She is also a US Army Reserve Innovation Officer, Major/O-4 in the 75</span><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">th</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> US Army Innovation Command. From August 2009 through July 2025, Dr. Rubins served as an Astronaut in the National Aeronautics and Space Administration (NASA). Dr. Rubins received her Ph.D. in Cancer Biology from Stanford University and a Bachelor of Science in Molecular Biology from the University of California, San Diego (UCSD).</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In connection with her appointment, Dr. Rubins will be entitled to receive compensation consistent with that of the Company&#8217;s other non-employee directors under the Company&#8217;s Non-Employee Director Compensation Policy, as such policy may be amended from time to time.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Dr. Rubins is not a party to any transaction with the Company that would require disclosure under Item 404(a) of Regulation S-K, and there are no arrangements or understandings between Dr. Rubins and any other persons pursuant to which she was selected as a director.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company also entered into its standard form of indemnification agreement with Dr. Rubins, which will require the Company to indemnify Dr. Rubins against certain liabilities that may arise as a result of her status or service as a director of the Company. The description of the Company&#8217;s standard form of indemnification agreement is qualified in its entirety by reference to the full text of the form of indemnification agreement, a copy of which is filed as Exhibit 10.19 to the Company&#8217;s Annual Report on Form 10-K filed with the SEC on February 24, 2026.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item 7.01 Regulation FD Disclosure.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">A copy of the Company&#8217;s press release announcing the appointment of Dr. Rubins to the Board has been furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated by reference into this Item 7.01.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The information in this report furnished pursuant to Item 7.01, including Exhibit 99.1 attached hereto, shall not be deemed &#8220;filed&#8221; for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), or otherwise subject to the liabilities of that section. It may only be incorporated by reference in another filing under the Exchange Act or the Securities Act of 1933, as amended, if such subsequent filing specifically references the information furnished pursuant to Item 7.01 of this report.</span></p><h2 style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item 9.01 Financial Statements and Exhibits.</span></h2><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
   <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
    <tr style="visibility:collapse;">
     <td style="width:12.92%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:86.08%;box-sizing:content-box;"/>
    </tr>
    <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="fblg-ex99_1.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Exhibit 99.1</span></a></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;text-align:right;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><a href="fblg-ex99_1.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Press Release</span></a></p></td>
    </tr>
    <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Exhibit 104</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:middle;padding-bottom:0in;padding-right:0in;text-align:right;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Cover Page Interactive Data File (embedded within the inline XBRL document)</span></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;min-height:0.5in;justify-content:flex-end;position:relative;"></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="z-index:2;min-height:0.5in;position:relative;"></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:9.35pt;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">SIGNATURES</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:9.35pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</span></p>
   <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
    <tr style="visibility:collapse;">
     <td style="width:6%;box-sizing:content-box;"/>
     <td style="width:44%;box-sizing:content-box;"/>
     <td style="width:4%;box-sizing:content-box;"/>
     <td style="width:46%;box-sizing:content-box;"/>
    </tr>
    <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;text-align:left;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:4.3pt;font-family:Times New Roman;margin-bottom:4.3pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">FibroBiologics, Inc.</span></p></td>
    </tr>
    <tr style="word-break:break-word;white-space:pre-wrap;text-align:left;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;text-align:left;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:4.3pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Date:</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:4.3pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">July 9, 2026</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:4.3pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">By:</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.25pt solid;padding-right:0in;"><p style="font-size:10pt;margin-top:4.3pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;">/s/ Pete O'Heeron</span></p></td>
    </tr>
    <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;text-align:left;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0.7pt;font-family:Times New Roman;margin-bottom:9.35pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Name:	Pete O'Heeron<br/>Title:	Chief Executive Officer</span></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;min-height:0.5in;justify-content:flex-end;position:relative;"></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
 </body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>fblg-ex99_1.htm
<DESCRIPTION>EX-99.1
<TEXT>
<!-- DFIN ActiveDisclosure (SM) HTML Document - http://www.dfinsolutions.com/ --><!-- Creation Date :2026-07-08T20:31:06.7133+00:00 --><!-- Copyright (c) 2026 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<html>
 <head>
  <title>EX-99.1</title>
 </head>
 <body style="padding:8px;margin:auto!important;z-index:0;-webkit-text-size-adjust:100%;position:relative;">
  <div style="padding-top:0.5in;z-index:2;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Aptos',sans-serif;font-kerning:none;min-width:fit-content;">Exhibit 99.1</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><img src="img111178190_0.jpg" alt="img111178190_0.jpg" style="width:288px;height:92px;"></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:12pt;font-family:'Aptos',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">FibroBiologics Appoints Kathleen &#34;Kate&#34; Rubins, Ph.D. to Board of Directors</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-style:italic;font-kerning:none;min-width:fit-content;">Microbiologist, Retired NASA Astronaut, and Founding Director of the University of Pittsburgh Trivedi Institute for Space and Global Biomedicine Joins Board</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;" id="ole_link5"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">HOUSTON, July 9, 2026 /PRNewswire/ -- FibroBiologics, Inc. (Nasdaq: FBLG) (&#x201c;FibroBiologics&#x201d;), a clinical-stage biotechnology company with 270+ patents issued and pending with a focus on the development of therapeutics and potential cures for chronic diseases using fibroblasts and fibroblast-derived materials, today announced the appointment of Kathleen &#34;Kate&#34; Rubins, Ph.D. to its Board of Directors. </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">As a retired NASA astronaut</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">, microbiologist, and genomics scientist, </font><font id="ole_link3"></font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Dr. Rubins has conducted pioneering medical research on the immune response to infection at high-profile academic institutions and pioneered molecular, cellular, and genomic techniques for human health on board the International Space Station (ISS).</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Pete O'Heeron, Chief Executive Officer and Chairman of FibroBiologics, said, &#x201c;Kate has been an invaluable member of our Scientific Advisory Board since 2022, and her firsthand understanding of how the human body adapts and heals in extreme environments makes her a natural fit for this expanded role. As we continue to advance our fibroblast-based pipeline through clinical development, her perspective will help guide both our scientific strategy and our long-term vision for FibroBiologics.&#x201d;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;" id="ole_link4"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">FibroBiologics is pursuing a fundamentally different approach to treating chronic disease, and I have seen the depth of the science behind it</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">,&#x201d; said Dr. Rubins. &#x201c;I am honored to take on this expanded role and to help guide the company as it advances fibroblast cell therapy from the lab toward patients who need new treatment options.&#x201d;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Dr. Rubins is the Founding Director of the Trivedi Institute for Space and Global Biomedicine at the University of Pittsburgh School of Medicine. Selected by NASA in 2009 as part of Astronaut Group 20, she completed two spaceflights to the ISS, serving as a flight engineer on Expedition 48/49 and Expedition 63/64 and has logged a total of 300 days in space. During her first mission, she became the first person to sequence DNA in space, advancing research into how astronauts can diagnose illness and identify microbes aboard the space station. Dr. Rubins retired from NASA in 2025 after 16 years with the agency, and was elected to the National Academy of Medicine in 2025.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;" id="ole_link7"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Prior to joining NASA, Dr. Rubins was a Fellow and Principal Investigator at the Whitehead Institute for Biomedical Research at the Massachusetts Institute of Technology, where she led a lab studying </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">how the human immune system responds to serious infectious diseases and developing potential new treatments. She holds a B.S. in Molecular Biology from the University of California, San Diego, and a Ph.D. in Cancer Biology from Stanford University Medical School.</font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;min-height:1in;justify-content:flex-end;position:relative;"></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:2;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Aptos',sans-serif;font-kerning:none;min-width:fit-content;">Exhibit 99.1</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><img src="img111178190_0.jpg" alt="img111178190_0.jpg" style="width:288px;height:92px;"></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:12pt;font-family:'Aptos',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">For more information, please visit FibroBiologics' </font><font><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">website</font></font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">, email FibroBiologics at </font><font><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">info@fibrobiologics.com</font></font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"> or follow FibroBiologics on </font><font><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">LinkedIn</font></font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">, </font><font><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">YouTube</font></font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">, </font><font><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Facebook</font></font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"> or </font><font><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">X</font></font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">.</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">   </font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">About FibroBiologics</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Based in Houston, FibroBiologics is a clinical-stage biotechnology company developing a pipeline of treatments and seeking potential cures for chronic diseases using fibroblast cells and fibroblast-derived materials. FibroBiologics holds 270+ US and internationally issued patents/patents pending across various clinical pathways, including wound healing, multiple sclerosis, disc degeneration, psoriasis, orthopedics, human longevity, and cancer. FibroBiologics represents the next generation of medical advancement in cell therapy and tissue regeneration. For more information, visit </font><font><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">www.FibroBiologics.com</font></font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">General Inquiries:</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"><br></font><font style="color:#467886;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">info@fibrobiologics.com</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Investor Relations:</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"><br>Nic Johnson<br>Russo Partners<br>(212) 845-4242<br></font><font style="color:#467886;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">fibrobiologicsIR@russopr.com</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Media Contact:</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;"><br>Liz Phillips<br>Russo Partners<br>(347) 956-7697<br></font><font style="color:#467886;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">Elizabeth.phillips@russopartnersllc.com</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;min-height:1in;justify-content:flex-end;position:relative;"></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>img111178190_0.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img111178190_0.jpg
M_]C_X  02D9)1@ ! 0$ W #<  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" #1 I4# 2(  A$! Q$!_\0
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HI*6@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@!GWJ*/NUB^*/$^G>$-$NM5U
M6[2SLK=-\DLF>.<  #DDD@ #DD@#DT1BY248J[,ZE2%*#G-V2-B218QDG KR
M#QU^U!X*\%RO;1WCZU?(VUK?30) IYZR$A.",$ DC/2OF7XO_M&Z]\3+B>QL
MI)=(\/;F"6D3E99TQC]\P/(()^0?+S_%@-7D? Z]:_0<NX7]I%5,6[7Z+]6?
MB6>>(7LYNCEL;V^T_P!%_F?1FN?MK>([J2,Z3H.GV$8'SK=2/<%CZ@KY>/R-
M8W_#8_CWS0WDZ0J_\\_LTFW_ -&9_6O#./2DKZR.19?!65-'YK4XNSJJ^9UV
MO30^B=%_;4\4VMUG4]&TR_M<8\NU,D#Y['<6<8_#\:]=\#_M:>#O%310:G))
MX<O6"@K>8,!<@Y E'&!CJX3.1]*^&CCUS2\-]:Y,1PW@:T?<7*_+_@Z'IX'C
MK-\)).<^>/9K]5J?J?;74=W"LL+K)&P!#*<@@]ZFY_"OSO\ A7\=/$?PIN E
MI*=1TCH^EW4C>6!N+$QG_EFV2W(&#GD$@5]S^ ?'^D?$KP_!J^C3^=!)\KQM
M@202#&Z-USPPS_(@D$&OSG,\HKY;+WM8O9_Y]C]TX?XGPN>PY8^[46\7^:[H
MZREI*6O#/M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "DI:* *MQ<):Q-)(VU%!)+'  %? ?Q\^,ES\5?%$L5K
M<.OANR<BSAVE!*>AF<'DD\XS]U>P);/T1^UUX^?PQX"31+9V2\UMVA++D$0+
M@R\].<JF#U#FOB*OT7AC+8RC]<J+RC^K/PCQ SZ<9K+*$K+>7Z(***]N^ _[
M/A^(D:^(M?E-EX8A<D*#L:ZVD[@&_@0$$%AR<$#'4?<8W'4<OHNM7=DC\CRO
M*\5G&)CAL+&\G^'FSQ_2=%U'7[HVVEZ?=:C<*N\PV<#2N%R!G"@G'(_.NRA^
M GQ!N+(7:>%[T1;=V'VJ_P#WP6W9_"OI'4?C+X<^']HVB^!]%@,$&4%P0$@W
M8'S #YI.X+$C.,Y;K7.G]H[Q89-P33PO]T0-C_T/-?B^.\4<)1K.G32=O5_\
M _I++?!+$XB@JF(DTWZ+\[L^8]9\,ZOX;DC35]*OM,:0$QK>VSP[\8SMW 9Q
MD?G6;D>E?9>D?'VPU^W;2_&>B6]Q8S_+)-#%YD>-PQOC;.0.N03TX6O.OCE^
MSK::+I;^+?!3?:=!,8EFLXW,ODKCF6-LDLG<@GY>3G'"_6Y!QQ@LY:IMVE_7
MW'P'%?ACF/#\'6A>4%]_RMH_/J?/%=O\(OBCJ'PK\66^I6TLC6$K+'?6BX(G
MBSZ9'SKDE3D>F<$@\2.O-'>OT+$8>GBJ4J5173/R+!XNM@*\:]&5I1U/U%T7
M6;7Q!I-EJ5C)Y]G>1+-#)M(W(P!!P1D<'O6CCFOEW]C/XA->:?J7@ZZERUI_
MIEDO.?*9OWJ],8#E3R<GS3V%?47K7X5CL)+!8B5"73\NA_8.2YE#-L#3Q</M
M+5=GU1)1117 >X%%%% # !2?=W4[I7'?%#QY#\-_!.I:_-&;C[.H$<(;:9)&
M8*JY[#)&3@X )P:JG"52:A!:LPQ%>&&I2K5':,5=^B-O6O$6F>&[,W>JW]OI
MUJI ::ZF6- 2< 98@<USP^-'@5F*CQ?HH]S?Q ?GNK\^O&'C+5_'FM3:MK5Y
M)>74G #'"1KV1%Z*H]/Q.36%C.<#/?\ ^O7Z!3X57L^:M5L_(_$ZWB+4G7Y,
M+0O&_7?\-C]3;&^M]1LX;NUN([FUF19(IHF#)(A&0P(X(((Y%3B:)L@.N?K7
MS'\2_&NL>"_V9?!9TFY>QFOK:QM6N(R5D1#;%SL8'Y2=@&?0G'/(^5M)UB_\
M/ZG#J.FWDUE?PMN2XA<JX/?GT/.0>N>:\? \/SQM.=6,TK-I?(^FS7C:GE=:
ME0E2<G))O6UK]M-3]2,C%<S=?$CPO8W$MO<>(=,AGC8QR1R7<:LK X((+<$'
MM1\/M;N?$O@/0=6NPJW=]I\-Q+Y8PNYXU8X]LD]Z_/3XG<_$KQ9G_H+7?_HY
MZY<JRK^T:\J+E;E/1XBXDEDN$I8FG#FY^^G2Y^C>A^*M(\2^=_9.IVFH^3CS
M!:SK+LSG&=I.,X/Y&M>ODW]AG/VKQEZ;;/\ G/7UACC%<&8818'$SH7ORV_%
M)GNY%F4LWR^GC)1Y7*^GH[?H2T44E><>^+1110 4444 %%%% !124M ">]9*
M>(M,DU/^SA?VQO\ ./L_G+YF0,XVYSTYK5;[IKYLTS)_:='K]IE_])FKQ\?C
MG@Y4DHWYY*/WGJ8'!?7(U7>W)%R^X^E:*2EKV#RPHHHH CI>WI7A_P 5O$'Q
M T[QM%!X>ANSI_E(T?V:V$J.Q)#;V*'!]L\  \5[;"&\M=_#XYKS\/BXXBI.
MFHM<KMJM'Z'97PKH4X5')/F5[)ZKU)J*2EKT#C"BBB@!N*H:EK%EH]N)KV[A
MM82VT/-($!/ID]^#5^O'/VF_^1)LO3[<O_H$E>?C<0\'AYUDK\J.W!X=8O$0
MHWMS.QZU97D&H6R7-M,EQ XRDD;!E/T(ZU9]*X;X)_\ ),]$Y_Y9M_Z&U=T*
MVPU;ZQ1A5:MS)/[T8XBBJ%:=&]^5M?<Q:***ZC **** "BBB@ HHHH ***9+
MD1-MZXXJ?A0"=>HI1Q7A_P +?$'Q"U#QM+!K\%V-.*2&7[1:^5&C#&W8P49Y
MXQGD$GGK7MY[XZUQ8/%+&0<U%QUMJK,Z\5AGA:G(Y*6E]'=$E%%%=YR!1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %)2TC?=- 'PC^UQXA.L?%R
M:R_>"/2[6*WVLV5+L/-+ =N)%!_W:\4]:]%_:(O'O/C1XIE==I%PB8]EB10?
MQ KSO^ U^[Y535+ THKLC^-N(JTL1FN(J2=_>:^2T1TOPU\&O\0/'6C>'UD\
MM+R?$KAMK+$JEY"IP<-L5L9&,XSQ7U'\>/&$>DPVO@O1E2UL[6)/M*0C:  !
MY<0 Z +@XQW7WKR[]C.,-\5+YR,[=*DQQW\V+FI?B#>37WCK7Y9I&E?[=-&&
M;^ZKE5'X!0/P%?@OBEFE:DEAZ;LGI^K_ ,C^I/!'):%2#Q=17E=O[M%_F<]1
M117\Q']D!7K'P%\?2Z-KJ:!>2@Z9J#%8Q)_RRF(XQD]&QC'J5QWSY/4UG>36
M%Y!=6[F.>"198W_NL""#^=>IEN,G@L5"K!VLU]W5'D9K@:>882="HKW3^_HS
M#^/_ (!B^'?Q,U"QM$6.PNU%[:HN/DC<G*X   #JX [*%KSGWKZ@_;>C077@
MR78HDDCN@S8Y(!AP,_B?SKY?;[U?WWD>(EBLOI5)[V_+0_RVXJP5/ 9O6HT]
MKW^]7L>A_L^^(O\ A&?B_P"&[EVD\FXN/L;K&2-WF@QJ#Z@,R'\ >U?HFC94
M$=Z_,KX=R-%\0O##KRRZI:L/KYJU^F<.?+3Z5\/Q732Q,)KJOR9^N>&U:4L#
M5I/92O\ >O\ @$U%%%?$'["%%%% $;L%7DU\Z_MJ3J_PYTD*XYU6,$ ]?W,U
M>L?&8G_A4OC' _YA%W_Z)>OS;'TS7UW#V7_6JWM^>W(UI;<_+>.,ZE@<,\&J
M?-[2+UO:WX"5^F?@WPWI'A7PW8:5IL,,%K;1JB@ 98XY9L=6)Y)[DYK\S>M-
M;[IK[C.LM>81A:IR*-_._P"*/R/A3/(Y+4G^X]HYV7I^#W_0_3/QUX)T?X@>
M'9]&UN$364N""IVO&X/RNK=B/\0<@D5XWI_[&_@RTU*.:XU34KVV1@WV:2:-
M5<#^%BJ X/\ LE34_P"V,Q_X538#M]OB_P#1<E?%9'Y5\ED^78K$8:52C7<$
MW:UO^"?I'%&=Y?A,?3I8G"*I))-2;M\MC]2[:VALK&.VMXUBMXD"1QQ@!54#
M   Z #^5?FS\3O\ DI7BS_L+W?\ Z.>OT"^%18_"_P ,9_Z!5M_Z)6OS]^)W
M_)2O%G_86N__ $<]:\+1Y<94B^WZF'B%453+<--*UW^A] ?L,GR[CQH2<#;9
M_P#M>OHS5?B1X6T.]^Q:EXBTRQN^/W-S>1QOSTX+9K\[-!\<:UX5TG5=.TF]
M?3X]3,/VF6 E92L>_"!ARH)?G')P!TR#@YZ\5Z>-X>>.QE2M4J<J=K6]$CY_
M*>-GE.64L)1H\\HWNWHM6WI\C]3K6\M[Z)9+>=)HV&5:,A@0>A!%3^H/)K\T
M/ 7Q(U_X:ZN+_1+UH,LIFM6.Z&X4'HZ]#WYZC)P17Z%?#WQI:?$+P?INO68(
MAO(]QC;.48$JZ'CG#!AGH<9'%?&YKD]7*VFWS1>S/U3ASBG#Y^I04>6I'5K?
M3NCHVFC4X+J#[FA9D?[KJWXU\+_M>?\ )8)?^O&'_P!FKS[X>_$*_P#AOJ&J
M:AI>%U"ZL7LX)& 81,TD;%\'J0%..,9QD$<5Z='AJIB,+'$4YW<DG:WZW/ Q
M?'M+!YA/!U:/NQ;3E?MY6/T.USQSX=\+O&FL:YI^EO*,HMY=1Q%@.XW$9K6M
M+R&_M8[BWF2:"50\<D;!E93R"".H-?EM=7<^H7,MS=3RW-Q*Q>2:9R[NQZDL
M>2<]\U^B7PEO(M+^#GAFZNIHX+:'2+>5Y)&"HBB)222>@ [FN/-<F>6TX/GY
MI2=MCT^'>+/[=KU8.GR1@KWO^9WS,%SD@"N?USX@>&_#,JPZMKVFZ=*PRL=U
M=1QDCUPQ%?'/QJ_:4UGQSJ4VG^'KR?2_#\3,BR0,T<MWVW,?O!?1..IW9X \
M0Z5Z.#X8JUJ:J5Y\M^G4\/,_$*CAZSH8*E[2W6^GR74_4#0_%6D^)+4W&E:E
M::C#G'F6LZR+GTRI-:V1CKFOROLKRXT^[BNK.XDM;J%M\<T+E'1O52.17U3^
MSG^TG>:IJ5IX6\5W"RS3#RK+49#M:1NT<AZ%CT#=20 <DY.&8<-UL)3=:E+G
MBOO.W)./,/F-=8;$P]G-Z)WNF_T/JCK7S?I?/[3P_P"OJ7_TF:OI#J,BOD[Q
M3XD_X1#XV:EJXC,K6LKE4[%F@*KGVRPS[5^/\05(TEAYRV4TW\C^@.'Z<JWU
MF$-W3:7S/JB\OK>Q@::YGCMXD&6>1PJCZDUF:=XTT+6KCR-/UBQO)L9V07".
MV/7 ->0Z9\&];^(C+K7C35;F"28%HK&+ ,*D#'7(3IRH'H2<YJ36OV8;+["[
M:5JMRMW@E5O-K(QP>/E52N3CGGZ&NJ6.Q\E[2E0]WS=F_D<4<'@(OV=6O[WD
MKI?/J>Z_>Z<T[H.U?/WPH^).K>'?$A\'^*&E9_-,44]PV7BDZA"Q^\K9&TY)
MY '!&/H#Z=*]/ XZ&.I\\59K1I[I]CS\;@IX&IR2=T]4ULUW0QI(U;YF4&GU
M\U_'/_DLFB_]<+7_ -'R5](QY\M/I483&_6:]6ERVY';U+Q.#^KT:5;FOSIO
MTL*>]5[N_M]/A:2XGC@B099I&"JH]237$_%CXF)\.]'5HXQ/J=UN2VB8?*"
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M/$+$8&FUT5ONT/Y#XLP<L%F]>,EI)\R^>I[)^R?XABT/XP6L,R\:G:RV:ON
M"MQ("?KY>WURPKK?C)H!\/?$+5HU#>5<O]KC+$9(DY8\=M^X?A7-?LF^!YO$
MOQ,BUAE4:=HB&>5F4,&E=66-.3P>6?(!QY8Z9!KI?C%XC7Q-\0-3FBDWV]NP
MMH3CLG#?4;]Q!]#7X#XJRP[DDG[^GW_\-8_JKP.CBXX9N:]S6WII^IQ5%%%?
MSCRRW/ZSYH[!6AX?TU=8\0:98.2L=U<QP,5ZX9P/ZUGUZ!\"K7[1\4-'.1MB
M\YR#W_=,/SY'Y5W9?15;%TJ;ZR2_$\_,JSP^#JU%O&+?X%/]M?6HKCQ/X;T<
M(WG6=G).S=B)750![@PG\Q7S=7K'[4EY/=?&[7XY9&DCMEMX85/1%\E&VCVW
M.Q_$UY1U-?Z 9'15'+Z,/*_WZ_J?Y7\58EXK.<1-])-?=H=;\(M-GU;XH>%;
M>WC,LG]IP2LJC^!'#N?P56/X5^E,?W /:OB?]CGP6VM>/KO7Y4'V?1X,1L20
M?.E!48XP0$$F<G^)?P^V/N\]J_/N*,1&MC/9Q^RK'[7X>8.5#+)5Y+XWIZ+3
M_,DHI*6OD#]4"BBB@"-E# BOG3]M>%4^'>D;5 /]JQ]!_P!,9J^C?4U\[?MM
M?\D[TC_L*Q_^B9J];*'_ +=2]3Y/BF*_LC$-_P I\7U^I]K;1_9XCL7[H[>U
M?EA7ZJ6O_'O%_NC^5?7<7-\U&WG^A^:>&<8R6)NOY?U/!OVT/^27V?\ V$8O
M_0)*^)*^V_VT/^286?\ V$8O_0)*^)*]7AC_ '&7J_T/G>/_ /D<Q](GZ4_"
MK_DEOA?_ +!=O_Z*6OS\^)W_ "4KQ9_V%KO_ -'/7Z!_"G_DE?A?_L%VW_HI
M:_/SXG?\E*\6_P#86N__ $<]>-PS_OU;Y_F?3\=_\BG"?+\CUC]D?X=Z'XX\
M0:W?:U9IJ(TR.$06MPH>$M)Y@+,A&&("<9XY)QD CZJ\:?#7P]XVT&33=3TV
M%XEB*0N(U$EN2,9C;'RD8'3T]*^?OV%_^/GQF?\ 9L_YSU]6R?<?Z5X^>XBK
M',IVD_=M;RT1]1P?@<-4R&'-33Y[WTWU:/RZUO2)?#^N:CID[*\UC<26TC)G
M:61BI(SVXKZF_8?UF672_%.E-M^SP3P72?WMTBLK?AB)?UKYP^)W_)2?%G_8
M7O/_ $<]>X_L0PS-XD\2R#/V=;:%9/3<6;;^@;]:^USC]_D_M)[VB_R/RGA>
M^%XE5*GM>2^6IRG[7G_)8)/^O*'^;5YO\//!EQ\1/&6F>'K:=+62]D8&9P2(
MT5"[' Y)VJ<#C)QR.M>D?M=_\E@E_P"O*'^;5C?LP\?'+PT?>X_])Y:WP]2=
M')E4INS4+_@<>.P]/%<3NC45XRJ)/T;U/IC1_P!D?X?6-AY-W976I2Y)^T7%
MY(K\]L1E5_2LO]IJ_7X<_!&U\/Z2'AMKEX=+5O-(=(%0L1GOD1[#GJ'-?0'0
M<5\P_MO0S'0_#$@#?9UN95?TW%!M_' :OSS+ZU7'8^E"O-R5[ZN^Q^W9Y@\-
ME&3XBI@J:@^6UTK.STW^9\C]CZU^@WP9^#>C_#?PO8[K""37)(0]Y>L \AD8
M#>JN0"$!& !@8&3R23^?:LJR(3TW G\Z_4^W_P!1'CLHKZGBRM4A&E3B[)WO
M\K?YGY[X;X.C7J5Z]2-Y1LE?I>]SYE_:R^#ND6_A>3QCI=K#IUY:2H+OR4"+
M<1R.%R5 Y<.R_-QP6SG"X^3(+B6UN(IX)'AGB8/')&Q5D8<A@>Q!'Z5^@O[2
M4D$/P6\2-<8\LPJJY_OF10G_ (\17Y[<;?\ :KNX9JSKX*4*CO9V^5D>1Q[A
M:."S6%2A'E;2;MWN]?P/TP^'/B)_%W@30M8E\L37EG'-*(ON*Y4%U')X#9'7
MM7AT5E!J'[2WD7$8EC^V%]K=-R0%U/U#*#7H?[,4<L7P1\.";<&*RL,_W3,Y
M7\,$5P6FG'[3@/\ T\R_^DS5^"<44HPQ5*DM4JJ7XG]6<'UY5LNG6EI)T;_-
MI'TH.,"EI*6OHSRCYS_:8TG^S]:T76[<213R!HGFC.-K(0T9'^UR_/\ LCTK
MW;PWJRZ[X?T_444HMS;QS!3U 90V/UKRO]IYE_X1/3!D;OMRD?\ ?MZ]"^&K
M?\6^\._]>$'_ *+6OEL''V>:8B$=FD_F?1XN?M,LP\I+6+DOEN>(?'+_ )+)
MHW_7"U_]'R5])1_ZE/\ =KYM^.7_ "631O\ KA:_^CY*^D5_U"_[G]*G*_\
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MC[4JW?\ RS/ 5W7'+_="1@?+\H W8"_/OQB_:"USXH75Q9P22:7X:WXBL8R
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M/XDD3$<8(=;-2,%0>A<@D%AQC@'!);]JR;BBA+*8U$[R2LEW[?=U]#^>>(>
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M8).U%  &3ST'>M&C\:6OS1MR=V?O\(JG%0BK)#Z***1H%%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 F!Z48'I2T4 )2T44 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
C%%%% !1110 4444 %%%% !1110 4444 %%%% !1110!__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>4
<FILENAME>fblg-20260702.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- DFIN New ActiveDisclosure (SM) XBRL Schema Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date :2026-07-08T20:31:07.0134+00:00 -->
<!-- Copyright (c) 2026 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<xsd:schema targetNamespace="http://fibrobiologics.com/20260702" attributeFormDefault="unqualified" elementFormDefault="qualified" xmlns:enum2="http://xbrl.org/2020/extensible-enumerations-2.0" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:us-gaap="http://fasb.org/us-gaap/2026" xmlns:fblg="http://fibrobiologics.com/20260702" xmlns:dei="http://xbrl.sec.gov/dei/2026" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xlink="http://www.w3.org/1999/xlink">
  <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance"/>
  <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase"/>
  <xsd:import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt"/>
  <xsd:import schemaLocation="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd" namespace="http://fasb.org/us-gaap/2026"/>
  <xsd:import schemaLocation="https://xbrl.sec.gov/dei/2026/dei-2026.xsd" namespace="http://xbrl.sec.gov/dei/2026"/>
  <xsd:annotation>
    <xsd:appinfo>
      <link:roleType roleURI="http://fibrobiologics.com/20260702/taxonomy/role/DocumentDocumentAndEntityInformation" id="Role_DocumentDocumentAndEntityInformation">
        <link:definition>100000 - Document - Document And Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:linkbase id="lnk">
        <link:roleRef roleURI="http://fibrobiologics.com/20260702/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:href="fblg-20260702.xsd#Role_DocumentDocumentAndEntityInformation" xlink:type="simple"/>
        <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:title="labelLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_DocumentType" xlink:label="dei_DocumentType"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications"/>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_CoverAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cover [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_AmendmentFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Amendment Flag</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_CityAreaCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label">City Area Code</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Period End Date</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentType_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Type</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line One</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, City or Town</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Postal Zip Code</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, State or Province</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Central Index Key</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Emerging Growth Company</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityExTransitionPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Ex Transition Period</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityFileNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity File Number</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation, State or Country Code</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityRegistrantName_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Registrant Name</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Tax Identification Number</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_LocalPhoneNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Local Phone Number</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Pre-commencement Issuer Tender Offer</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Pre-commencement Tender Offer</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_Security12bTitle_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Title of 12(b) Security</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_SecurityExchangeName_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Security Exchange Name</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_SolicitingMaterial_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Soliciting Material</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_TradingSymbol_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Trading Symbol</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_WrittenCommunications_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Written Communications</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl"/>
        </link:labelLink>
        <link:presentationLink xlink:role="http://fibrobiologics.com/20260702/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_DocumentType" xlink:label="dei_DocumentType"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AmendmentFlag" order="10010.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CityAreaCode" order="10130.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentPeriodEndDate" order="10020.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentType" order="10000.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine1" order="10090.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressCityOrTown" order="10100.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressPostalZipCode" order="10120.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressStateOrProvince" order="10110.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCentralIndexKey" order="10040.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityEmergingGrowthCompany" order="10050.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityExTransitionPeriod" order="10200.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityFileNumber" order="10060.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityIncorporationStateCountryCode" order="10070.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityRegistrantName" order="10030.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityTaxIdentificationNumber" order="10080.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_LocalPhoneNumber" order="10140.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementIssuerTenderOffer" order="10190.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementTenderOffer" order="10180.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_Security12bTitle" order="10210.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SecurityExchangeName" order="10340.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SolicitingMaterial" order="10170.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_TradingSymbol" order="10220.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_WrittenCommunications" order="10160.0" priority="2" use="optional"/>
        </link:presentationLink>
      </link:linkbase>
    </xsd:appinfo>
  </xsd:annotation>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>6
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document And Entity Information<br></strong></div></th>
<th class="th"><div>Jul. 02, 2026</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jul.  02,  2026<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">FibroBiologics, Inc.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001958777<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-41934<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">86-3329066<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">9350 Kirby Drive, Suite 300<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Houston<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">TX<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">77054<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">281<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">671-5150<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Entity Ex Transition Period</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, $0.00001 par value<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">FBLG<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14a<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>7
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.26.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>23</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="fblg-20260702.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>100000 - Document - Document And Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fibrobiologics.com/20260702/taxonomy/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document And Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" isOnlyDei="true" isUsgaap="true" original="fblg-20260702.htm">fblg-20260702.htm</File>
    <File>fblg-20260702.xsd</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="23">http://xbrl.sec.gov/dei/2026</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>false</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>12
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "fblg-20260702.htm": {
   "nsprefix": "fblg",
   "nsuri": "http://fibrobiologics.com/20260702",
   "dts": {
    "inline": {
     "local": [
      "fblg-20260702.htm"
     ]
    },
    "schema": {
     "local": [
      "fblg-20260702.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd",
      "https://xbrl.fasb.org/srt/2026/elts/srt-2026.xsd",
      "https://xbrl.fasb.org/srt/2026/elts/srt-roles-2026.xsd",
      "https://xbrl.fasb.org/srt/2026/elts/srt-types-2026.xsd",
      "https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd",
      "https://xbrl.fasb.org/us-gaap/2026/elts/us-roles-2026.xsd",
      "https://xbrl.fasb.org/us-gaap/2026/elts/us-types-2026.xsd",
      "https://xbrl.sec.gov/country/2026/country-2026.xsd",
      "https://xbrl.sec.gov/dei/2026/dei-2026.xsd",
      "https://xbrl.sec.gov/stpr/2026/stpr-2026.xsd"
     ]
    }
   },
   "keyStandard": 23,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2026": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 24,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2026": 23
   },
   "report": {
    "R1": {
     "role": "http://fibrobiologics.com/20260702/taxonomy/role/DocumentDocumentAndEntityInformation",
     "longName": "100000 - Document - Document And Entity Information",
     "shortName": "Document And Entity Information",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "C_a9b4a05e-f434-40f1-aa9d-e49c11ce14e9",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "h2",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fblg-20260702.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_a9b4a05e-f434-40f1-aa9d-e49c11ce14e9",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "h2",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "fblg-20260702.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://fibrobiologics.com/20260702/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "CityAreaCode",
     "presentation": [
      "http://fibrobiologics.com/20260702/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://fibrobiologics.com/20260702/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "DocumentType",
     "presentation": [
      "http://fibrobiologics.com/20260702/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://fibrobiologics.com/20260702/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://fibrobiologics.com/20260702/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://fibrobiologics.com/20260702/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://fibrobiologics.com/20260702/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://fibrobiologics.com/20260702/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://fibrobiologics.com/20260702/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://fibrobiologics.com/20260702/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Ex Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://fibrobiologics.com/20260702/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://fibrobiologics.com/20260702/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://fibrobiologics.com/20260702/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://fibrobiologics.com/20260702/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://fibrobiologics.com/20260702/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://fibrobiologics.com/20260702/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://fibrobiologics.com/20260702/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "Security12bTitle",
     "presentation": [
      "http://fibrobiologics.com/20260702/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://fibrobiologics.com/20260702/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://fibrobiologics.com/20260702/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "TradingSymbol",
     "presentation": [
      "http://fibrobiologics.com/20260702/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://fibrobiologics.com/20260702/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>13
<FILENAME>0001193125-26-299290-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001193125-26-299290-xbrl.zip
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MDA+J-SP+N35?A;VXQ'&=SD\E-)/FZ;AKM Q[G!.>%GXLR,^:^MD-H6@E)T!
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MAD^9I@'_,<W@F@L.7\=:#68^1+& NGTAGW7\P1"EUDR<9@. &1.>@V./@\G
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M+!%L&"49SZ]69_Y$$08L^S?K.N,D,T;1R[.Z2Y>-!5@V4?QX7B5=H N#?O^
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M2P$"% ,4    " #O:^E<G0FJJ8P7   )Q@  $0              @ $
M9F)L9RTR,#(V,#<P,BYH=&U02P$"% ,4    " #O:^E<8"S[A9\(   :80
M$0              @ &[%P  9F)L9RTR,#(V,#<P,BYX<V102P$"% ,4
M" #O:^E<*\Q'(3L+  "@0@  #P              @ &)(   9F)L9RUE>#DY
<7S$N:'1M4$L%!@     #  , NP   /$K      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>fblg-20260702_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2026"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="fblg-20260702.xsd" xlink:type="simple"/>
    <context id="C_a9b4a05e-f434-40f1-aa9d-e49c11ce14e9">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001958777</identifier>
        </entity>
        <period>
            <startDate>2026-07-02</startDate>
            <endDate>2026-07-02</endDate>
        </period>
    </context>
    <dei:AmendmentFlag
      contextRef="C_a9b4a05e-f434-40f1-aa9d-e49c11ce14e9"
      id="F_7abf7119-9615-4c0b-9929-e4861497e7c5">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey
      contextRef="C_a9b4a05e-f434-40f1-aa9d-e49c11ce14e9"
      id="F_5f429da3-957d-431f-b4d8-55a3194a5b34">0001958777</dei:EntityCentralIndexKey>
    <dei:DocumentType
      contextRef="C_a9b4a05e-f434-40f1-aa9d-e49c11ce14e9"
      id="F_c65c1e5e-9d1d-4fe9-b037-49d8c7959417">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate
      contextRef="C_a9b4a05e-f434-40f1-aa9d-e49c11ce14e9"
      id="F_5d78c504-1783-46ca-89a6-4da7c37c9dfe">2026-07-02</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName
      contextRef="C_a9b4a05e-f434-40f1-aa9d-e49c11ce14e9"
      id="F_185f6a94-5aeb-4fba-889b-76001835fbc3">FibroBiologics, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="C_a9b4a05e-f434-40f1-aa9d-e49c11ce14e9"
      id="F_9e2bb745-f78b-4a43-b9ca-26ecd776de39">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber
      contextRef="C_a9b4a05e-f434-40f1-aa9d-e49c11ce14e9"
      id="F_84d9b4d1-b642-432b-a00d-ba02d0837c64">001-41934</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber
      contextRef="C_a9b4a05e-f434-40f1-aa9d-e49c11ce14e9"
      id="F_1dda705e-abc3-4599-a399-1b3a7e4e9d4e">86-3329066</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="C_a9b4a05e-f434-40f1-aa9d-e49c11ce14e9"
      id="F_03cbc71a-bf2e-468f-b123-343146e2938c">9350 Kirby Drive, Suite 300</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="C_a9b4a05e-f434-40f1-aa9d-e49c11ce14e9"
      id="F_123de368-df3f-46e6-abe9-952a9d8fb44d">Houston</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="C_a9b4a05e-f434-40f1-aa9d-e49c11ce14e9"
      id="F_b23f5531-23e3-42b9-bf84-d51793e66859">TX</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="C_a9b4a05e-f434-40f1-aa9d-e49c11ce14e9"
      id="F_271038da-9c13-403c-84b4-c477ff0f2c90">77054</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="C_a9b4a05e-f434-40f1-aa9d-e49c11ce14e9"
      id="F_6541e654-62ca-4d92-8fc1-91db1429686b">281</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="C_a9b4a05e-f434-40f1-aa9d-e49c11ce14e9"
      id="F_e1a21691-39b7-432e-b261-07f6d1c17512">671-5150</dei:LocalPhoneNumber>
    <dei:WrittenCommunications
      contextRef="C_a9b4a05e-f434-40f1-aa9d-e49c11ce14e9"
      id="F_608abc22-51ab-4512-a24d-f7b1727be683">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial
      contextRef="C_a9b4a05e-f434-40f1-aa9d-e49c11ce14e9"
      id="F_ad1599e1-cf04-4048-a91c-53ebe494e4d2">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer
      contextRef="C_a9b4a05e-f434-40f1-aa9d-e49c11ce14e9"
      id="F_af21b2f4-ed42-44bb-b480-7d73e494e444">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer
      contextRef="C_a9b4a05e-f434-40f1-aa9d-e49c11ce14e9"
      id="F_2485b67b-8475-45a4-a3f2-bbbd34beecb2">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle
      contextRef="C_a9b4a05e-f434-40f1-aa9d-e49c11ce14e9"
      id="F_d3096739-13e3-45a9-8357-816a4747eeca">Common Stock, $0.00001 par value</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="C_a9b4a05e-f434-40f1-aa9d-e49c11ce14e9"
      id="F_c220cb3e-8a66-4b30-964d-dd03a2d6e887">FBLG</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="C_a9b4a05e-f434-40f1-aa9d-e49c11ce14e9"
      id="F_bb38d109-68c9-4007-a622-b0ee88f1f50d">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany
      contextRef="C_a9b4a05e-f434-40f1-aa9d-e49c11ce14e9"
      id="F_be48f5ba-e685-4fad-be5c-3d5728dcc293">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod
      contextRef="C_a9b4a05e-f434-40f1-aa9d-e49c11ce14e9"
      id="F_0ba7bac9-0e5a-4bee-a045-dd58db5ea521">false</dei:EntityExTransitionPeriod>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
